IL1R1 and inflammatory bowel disease: Fibroblast IL-1R signaling drives the recruitment of neutrophils, which then induces inflammation, indicating that targeting the neutrophil-attractant program in fibroblasts by blocking IL-1R could be used as an alternative treatment for patients with refractory IBD.